| {"0": "Metabolism of spingolipids in er and golgi apparatus", "1": "Mitochondrial complex iv assembly", "2": "Sphingolipid metabolism overview", "3": "Sphingolipid metabolism integrated pathway", "4": "Kennedy pathway from sphingolipids", "5": "Sphingolipid metabolism in senescence", "6": "Sphingolipid pathway", "7": "Familial partial lipodystrophy fpld", "8": "Electron transport chain oxphos system in mitochondria", "9": "Overlap between signal transduction pathways contributing to lmna laminopathies", "10": "Mitochondrial complex i assembly model oxphos system", "11": "Cholesterol biosynthesis pathway", "12": "Nonalcoholic fatty liver disease", "13": "Oxidative phosphorylation", "14": "Influence of laminopathies on wnt signaling", "15": "Mitochondrial long chain fatty acid betaoxidation", "16": "Ferroptosis", "17": "Adipogenesis", "18": "Spinal cord injury", "19": "Cholesterol metabolism with bloch and kandutschrussell pathways", "20": "Vitamin d receptor pathway", "21": "Mirna regulation of prostate cancer signaling pathways", "22": "Genes related to primary cilium development based on crispr", "23": "Regucalcin in proximal tubule epithelial kidney cells", "24": "Metapathway biotransformation phase i and ii", "25": "G1 to s cell cycle control", "26": "Fatty acid betaoxidation", "27": "Ciliopathies", "28": "4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression", "29": "Ppar signaling pathway", "30": "Proximal tubule transport", "31": "Aryl hydrocarbon receptor pathway wp2586", "32": "Alzheimers disease and mirna effects"} |